HbA1c and estimated average glucose (ADAG)
Maps HbA1c to estimated average glucose over the past 2 to 3 months (and vice versa) using ADAG linear regression.
Calculate with transparency
Check the population, units and version. The result shows the formula or classification; it does not make an automatic treatment decision.
Preparing the form…
- Check the method
- Enter the data
- Check the result
Method · Limits of application
ADAG/Nathan 2008: eAG mg/dL 28.7 HbA1c−46.7; mmol/L 1.59 HbA1c−2.59
The ADAG 2008 regression was studied over three months in participants with relatively stable glycemia. Children, pregnant women and people with erythrocyte conditions were excluded; anemia, altered erythrocyte turnover and hemoglobinopathies may affect interpretation of HbA1c. Estimated average glucose is not a direct measurement, and the algebraic inverse is not an independent diagnostic test. The unit and coefficient variant must be preserved.
Conditions of use
Check the population, units, inclusion and exclusion criteria, and version in the original source. A result alone does not establish a diagnosis, discharge decision or prescription.
Documented parameters
- HbA1c · %
- or mean blood glucose (if HbA1c is not entered) · mg/dL
6/6 reference cases checked. Numerical tests are not clinical validation.
Relationship with cancer research
General context — relationship to be defined
A resource for general clinical contexts. This edition does not assign a specific oncological relationship; selecting it for a study requires a justified question, population and purpose.